International Clinical Trial: Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled Trial

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07818356) titled 'Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled Trial' on Sept. 7.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: University Hospital, Toulouse

Condition: Vaccine Varicella-zoster Virus Multiple Sclerosis Spectrum Disease Neuromyelitis Optica

Intervention: Biological: Two-dose M0-M2 vaccination schedule

R...